Discover 3,617 paid clinical trials in Orange County, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Orange County offers clinical trials for a variety of conditions, including high blood pressure, heart disease, and skin disorders such as eczema, alopecia, and psoriasis. The city’s medical institutions are actively recruiting both healthy volunteers, as well as those with specific health needs to participate in studies that could improve treatments and outcomes for these, and many other widespread health issues.
Filter
2
Filter results
Results: 3,617
Real-Time Diagnosis of Life-Threatening Necrotizing Soft Tissue Infections (NSTI) Using Indocyanine Green (ICG) Kinetic Modeling
for
Necrotizing Fascitis
Location: Los Angeles CA, Stanford CA, Nashville TN, Atlanta GA,
Sponsor: Eric R. Henderson
Sex: All
Age: 18+
Code: NCT06877793
Recruiting
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
Location: Fullerton CA, Long Beach CA, Pasadena CA,
Sponsor: Amgen
Sex: All
Age: 50+
Code: NCT07614776
Phase 3, Recruiting
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
for
Small Cell Lung Cancer, Small Cell Lung Cancer ( SCLC ),
Location: Irvine CA, Duarte CA, Vista CA, Encinitas CA,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07476287
Phase 2, Recruiting
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
for
Advanced Solid Tumors, MSI-H or dMMR Advanced Solid Tumors,
Location: Los Angeles CA, Fort Worth TX, Houston TX,
Sponsor: Eikon Therapeutics
Sex: All
Age: 18+
Code: NCT07262619
Phase 1, Phase 2, Recruiting
Hepatitis C Tracker Study
for
Hepatitis C Virus Infection
Location: Alhambra CA, Ventura CA
Sponsor: University of Southern California
Sex: All
Age: 18+
Code: NCT06870019
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
for
Geographic Atrophy, Macular Degeneration
Location: Fullerton CA, Pasadena CA, Poway CA, La Jolla CA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 60+
Code: NCT06635148
Phase 2, Phase 3, Recruiting
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
for
Small Cell Lung Cancer
Location: Fullerton CA, Los Angeles CA, San Francisco CA,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06203210
Phase 3, Recruiting
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
for
Breast Cancer
Location: Fullerton CA, Irvine CA, Whittier CA, Duarte CA,
Sponsor: Greenwich LifeSciences, Inc.
Sex: All
Age: 18 - 70+
Code: NCT05232916
Phase 3, Recruiting
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
for
End of Life, Cancer
Location: Fullerton CA, Duarte CA, Los Angeles CA, Fresno CA,
Sponsor: Stanford University
Sex: All
Age: 18+
Code: NCT05297734
Recruiting
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
for
Systemic Lupus Erythematosus (SLE),
Location: Los Angeles CA, Thousand Oaks CA, Allen TX,
Sponsor: EMD Serono Research & Development Institute, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07332481
Phase 3, Recruiting
Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
for
Acute Myeloid Leukemia
Location: Los Angeles CA, San Francisco CA, Kansas City KS,
Sponsor: Stichting Hemato-Oncologie voor Volwassenen Nederland
Location: Upland CA, Kelowna, Frisco TX, Humble TX, Houston TX,
Sponsor: EMD Serono Research & Development Institute, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07355218
Phase 3, Recruiting
Study of Cannabidiol in Sanfilippo Syndrome
for
Sanfilippo Syndrome, Mucopolysaccharidosis III
Location: Torrance CA
Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Sex: All
Age: 4+
Code: NCT06333041
Phase 2, Phase 3, Recruiting
Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer
for
Non Small Cell Lung Cancer
Location: Torrance CA, Monterey CA, Walnut Creek CA,
Sponsor: N-Power Medicine
Sex: All
Age: 18+
Code: NCT07028489
Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
for
Neoplasms
Location: Duarte CA, Aurora CO, San Antonio TX, Houston TX,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT06884618
Phase 1, Recruiting
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
for
Breast Cancer
Location: Fullerton CA, Los Angeles CA, Billings MT, Seattle WA,
Sponsor: Celcuity Inc
Sex: All
Age: 18+
Code: NCT06757634
Phase 3, Recruiting
FT839 in Autoimmune Diseases
for
ANCA-Associated Vasculitis (AAV),
Location: Fullerton CA
Sponsor: Fate Therapeutics
Sex: All
Age: 18 - 70
Code: NCT07800871
Phase 1, Phase 2, Recruiting
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease
for
Refractory Metastatic Colorectal Cancer
Location: Duarte CA, Santa Monica CA, Salt Lake City UT,
Sponsor: Delcath Systems Inc.
Sex: All
Age: 18+
Code: NCT06607458
Phase 2, Recruiting
Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast Cancer